Indicadors d'investigació de l'Institut de Recerca i Innovació Educativa. IRIE 2008-2012

El present informe recull la recerca educativa realitzada pels grups consolidats de l’Institut de Recerca i Innovació Educativa (IRIE) durant el període previ a la seva creació (2008-2012). Aquesta producció ha conformat la massa crítica que ha fet possible la creació de l’Institut i és el fruit del treball de cent cinquanta-vuit investigadors, integrats en onze grups de recerca. L’informe presenta les línies de recerca que desenvolupen i els principals productes de la seva tasca. Durant aquest període s’han dut a terme cent seixanta-sis projectes i contractes de recerca amb finançament estatal i quaranta-un projectes i contractes internacionals, i s’ha rebut un finançament total de 8.478.372,65 €. S’han publicat quatre-cents cinquanta-dos articles en revistes –cent seixanta-vuit dels quals indexats en bases d’impacte– i sis-cents seixanta-sis capítols o llibres científics. Al mateix temps s’han seguit formant nous investigadors en educació, ja que s’han llegit setanta-dues tesis doctorals. L’anàlisi d’aquests indicadors ens permet saber l’estat de la qüestió de la recerca educativa més especialitzada a les Illes Balears i tenir elements per a determinar el potencial investigador de l’IRIE per als propers anys.El presente informe recoge la investigación educativa realizada por los grupos consolidados del Institut de Recerca i Innovació Educativa (IRIE) durante el período previo a su creación (2008- 2012). Esta producción ha conformado la masa crítica que ha hecho posible la creación del instituto y es fruto del trabajo de 158 investigadores, integrados en once grupos de investigación. El informe presenta las líneas de investigación que desarrollan y los principales productos de su labor. Durante este período se han llevado a cabo 166 proyectos y contratos de investigación con financiación estatal y 41 proyectos y contratos internacionales; se ha recibido una financiación total de 8.478.372,65 €. Se han publicado 452 artículos en revistas –186 de los cuales indexados en bases de impacto– y 666 capítulos o libros científicos. Al mismo tiempo se ha seguido formando a nuevos investigadores en educación, ya que se han leído 72 tesis doctorales. El análisis de estos indicadores nos permite conocer el estado de la cuestión de la investigación educativa más especializada en las Illes Balears y tener elementos para determinar el potencial investigador del IRIE para los próximos años.This report contains the educational research provided by consolidated groups of the IRIE (Institute of Research and Educational Innovation) in the run-up to the Institute’s creation (2008-2012). This production has shaped the critical mass that has made possible the creation of the Institute and is the outcome of the work of 158 researchers consisting of 11 research groups. The report presents the lines of research and the main products of researchers task. During this time, 166 projects and research contracts with government funding and 41 projects and international contracts were achieved, with a total funding of 8.478.372,65 €. 452 articles in magazines –186 of them indexed in impact databases– and 666 chapters or scientific books have been published. At the same time, new educational researchers have been trained and 72 doctoral theses have been read. The analysis of these indicators allows us to know the state of play of the most specialized educational research in the Balearic Islands and to have items to determine the research potential of the IRIE for the coming years

Efficacy of a brief multifactorial adherence-based intervention on reducing the blood pressure of patients with poor adherence: protocol for a randomized clinical trial

<p>Abstract</p> <p>Background</p> <p>Lowering of blood pressure by antihypertensive drugs reduces the risks of cardiovascular events, stroke, and total mortality. However, poor adherence to antihypertensive medications reduces their effectiveness and increases the risk of adverse events. In terms of relative risk reduction, an improvement in medication adherence could be as effective as the development of a new drug.</p> <p>Methods/Design</p> <p>The proposed randomized controlled trial will include patients with a low adherence to medication and uncontrolled blood pressure. The intervention group will receive a multifactorial intervention during the first, third, and ninth months, to improve adherence. This intervention will include motivational interviews, pill reminders, family support, blood pressure self-recording, and simplification of the dosing regimen.</p> <p>Measurement</p> <p>The primary outcome is systolic blood pressure. The secondary outcomes are diastolic blood pressure, proportion of patients with adequately controlled blood pressure, and total cost.</p> <p>Discussion</p> <p>The trial will evaluate the impact of a multifactorial adherence intervention in routine clinical practice. Ethical approval was given by the Ethical Committee on Human Research of Balearic islands, Spain (approval number IB 969/08 PI).</p> <p>Trial registration</p> <p>Current controlled trials ISRCTN21229328</p

Effect of a mobile‐based intervention on mental health in frontline healthcare workers against COVID‐19: Protocol for a randomized controlled trial

To evaluate the impact of a psychoeducational, mobile health intervention based on cognitive behavioural therapy and mindfulness-based approaches on the mental health of healthcare workers at the frontline against COVID-19 in Spain. We will carry out a two-week, individually randomized, parallel group, controlled trial. Participants will be individually randomized to receive the PsyCovidApp intervention or control App intervention. The PsyCovidApp intervention will include five modules: emotional skills, lifestyle behaviour, work stress and burnout, social support, and practical tools. Healthcare workers having attended patients with COVID-19 will be randomized to receive the PsyCovidApp intervention (intervention group) or a control App intervention (control group). A total of 440 healthcare workers will be necessary to assure statistical power. Measures will be collected telephonically by a team of psychologists at baseline and immediately after the 2 weeks intervention period. Measures will include stress, depression and anxiety (DASS-21 questionnaire-primary endpoint), insomnia (ISI), burnout (MBI-HSS), post-traumatic stress disorder (DTS), and self-efficacy (GSE). The study was funded in May 2020, and was ethically approved in June 2020. Trial participants, outcome assessors and data analysts will be blinded to group allocation. Despite the increasing use of mobile health interventions to deliver mental health care, this area of research is still on its infancy. This study will help increase the scientific evidence about the effectiveness of this type of intervention on this specific population and context. Despite the lack of solid evidence about their effectiveness, mobile-based health interventions are already being widely implemented because of their low cost and high scalability. The findings from this study will help health services and organizations to make informed decisions in relation to the development and implementation of this type of interventions, allowing them pondering not only their attractive implementability features, but also empirical data about its benefits. NCT04393818 (ClinicalTrials.gov identifier). May 2020

Effect of a mobile-based intervention on mental health in frontline healthcare workers against COVID-19: Protocol for a randomized controlled trial.

To evaluate the impact of a psychoeducational, mobile health intervention based on cognitive behavioural therapy and mindfulness-based approaches on the mental health of healthcare workers at the frontline against COVID-19 in Spain. We will carry out a two-week, individually randomized, parallel group, controlled trial. Participants will be individually randomized to receive the PsyCovidApp intervention or control App intervention. The PsyCovidApp intervention will include five modules: emotional skills, lifestyle behaviour, work stress and burnout, social support, and practical tools. Healthcare workers having attended patients with COVID-19 will be randomized to receive the PsyCovidApp intervention (intervention group) or a control App intervention (control group). A total of 440 healthcare workers will be necessary to assure statistical power. Measures will be collected telephonically by a team of psychologists at baseline and immediately after the 2 weeks intervention period. Measures will include stress, depression and anxiety (DASS-21 questionnaire-primary endpoint), insomnia (ISI), burnout (MBI-HSS), post-traumatic stress disorder (DTS), and self-efficacy (GSE). The study was funded in May 2020, and was ethically approved in June 2020. Trial participants, outcome assessors and data analysts will be blinded to group allocation. Despite the increasing use of mobile health interventions to deliver mental health care, this area of research is still on its infancy. This study will help increase the scientific evidence about the effectiveness of this type of intervention on this specific population and context. Despite the lack of solid evidence about their effectiveness, mobile-based health interventions are already being widely implemented because of their low cost and high scalability. The findings from this study will help health services and organizations to make informed decisions in relation to the development and implementation of this type of interventions, allowing them pondering not only their attractive implementability features, but also empirical data about its benefits. NCT04393818 (ClinicalTrials.gov identifier). May 2020

A Mobile Phone-Based Intervention to Reduce Mental Health Problems in Health Care Workers During the COVID-19 Pandemic (PsyCovidApp): Randomized Controlled Trial.

The global health emergency generated by the COVID-19 pandemic is posing an unprecedented challenge to health care workers, who are facing heavy workloads under psychologically difficult situations. Mental mobile Health (mHealth) interventions are now being widely deployed due to their attractive implementation features, despite the lack of evidence about their efficacy in this specific population and context. The aim of this trial is to evaluate the effectiveness of a psychoeducational, mindfulness-based mHealth intervention to reduce mental health problems in health care workers during the COVID-19 pandemic. We conducted a blinded, parallel-group, controlled trial in Spain. Health care workers providing face-to-face health care to patients with COVID-19 were randomly assigned (1:1) to receive the PsyCovidApp intervention (an app targeting emotional skills, healthy lifestyle behavior, burnout, and social support) or a control app (general recommendations about mental health care) for 2 weeks. The participants were blinded to their group allocation. Data were collected telephonically at baseline and after 2 weeks by trained health psychologists. The primary outcome was a composite of depression, anxiety, and stress (overall score on the Depression Anxiety Stress Scale-21 [DASS-21]). Secondary outcomes were insomnia (Insomnia Severity Index), burnout (Maslach Burnout Inventory Human Services Survey), posttraumatic stress (Davidson Trauma Scale), self-efficacy (General Self-Efficacy Scale), and DASS-21 individual scale scores. Differences between groups were analyzed using general linear modeling according to an intention-to-treat protocol. Additionally, we measured the usability of the PsyCovidApp (System Usability Scale). The outcome data collectors and trial statisticians were unaware of the treatment allocation. Between May 14 and July 25, 2020, 482 health care workers were recruited and randomly assigned to PsyCovidApp (n=248) or the control app (n=234). At 2 weeks, complete outcome data were available for 436/482 participants (90.5%). No significant differences were observed between the groups at 2 weeks in the primary outcome (standardized mean difference -0.04; 95% CI -0.11 to 0.04; P=.15) or in the other outcomes. In our prespecified subgroup analyses, we observed significant improvements among health care workers consuming psychotropic medications (n=79) in the primary outcome (-0.29; 95% CI -0.48 to -0.09; P=.004), and in posttraumatic stress, insomnia, anxiety, and stress. Similarly, among health care workers receiving psychotherapy (n=43), we observed improvements in the primary outcome (-0.25; 95% CI -0.49 to -0.02; P=.02), and in insomnia, anxiety, and stress. The mean usability score of PsyCovidApp was high (87.21/100, SD 12.65). After the trial, 208/221 participants in the intervention group (94.1%) asked to regain access to PsyCovidApp, indicating high acceptability. In health care workers assisting patients with COVID-19 in Spain, PsyCovidApp, compared with a control app, reduced mental health problems at 2 weeks only among health care workers receiving psychotherapy or psychotropic medications. ClinicalTrials.gov NCT04393818; https://clinicaltrials.gov/ct2/show/NCT04393818